Discussing menstrual health in family medicine
Family Medicine and Community Health · 2024
DOI: 10.1136/fmch-2023-002149 ↗Kurz gefasst
Editorial in der Zeitschrift Family Medicine and Community Health, 2024. Verfasst von Allison R Casola und 2 weiteren Autor:innen. Beteiligte Einrichtung: Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA allison.casola@jefferson.edu. Hauptthemen laut MEDLINE: Family Practice, Women's Health. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Menstrual health is a general biological marker for many cisgender women, transgender men and non-binary people. Despite more than half of the population being people who menstruate, stigma, lack of conversation and pressing social needs around menstrual health persists throughout medicine.[1][1]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA allison.casola@jefferson.edu.
- Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.
- Lehigh Valley Health Network, Allentown, Pennsylvania, USA.
- Valley Health Partners Family Health Center, Allentown, Pennsylvania, USA.
ORCID-Profile: Allison R Casola, Alice Renaud
Zitieren
APA
Casola, A. R., Renaud, A., & Mulki, A. K. (2024). Discussing menstrual health in family medicine. Family Medicine and Community Health. https://doi.org/10.1136/fmch-2023-002149
Vancouver
Casola AR, Renaud A, Mulki AK. Discussing menstrual health in family medicine. Family Medicine and Community Health. 2024. doi:10.1136/fmch-2023-002149
BibTeX
@article{Casola2024,
author = {Casola, Allison R and Renaud, Alice and Mulki, Ashwini Kamath},
title = {Discussing menstrual health in family medicine},
journal = {Family Medicine and Community Health},
year = {2024},
doi = {10.1136/fmch-2023-002149}
}
EUVIMED